Grants for Public housing authorities - Health

This funding opportunity supports U.S.-based researchers and organizations in developing innovative cancer communication strategies using advanced technologies to improve cancer prevention, control, and patient care.

This funding opportunity provides financial support to early-career researchers currently holding specific NIAMS career development awards, helping them advance their research projects and transition to independent research careers in arthritis, musculoskeletal, and skin diseases.

This grant provides funding to researchers for planning clinical trials that improve cancer prevention, treatment, and care, addressing gaps in knowledge and feasibility to enhance study design and outcomes.

This funding opportunity supports healthcare systems in implementing and studying coordinated pain care models that improve pain management for underserved populations through collaborative, evidence-based approaches.

This funding opportunity supports high-risk, multi-center clinical trials aimed at addressing significant health issues related to diabetes, digestive diseases, and kidney disorders, encouraging diverse institutions to apply for impactful research that can transform clinical practices.

This FOA solicits the development of theories, computational models, and analytical tools to derive understanding of brain function from complex neuroscience data. Proposed projects could develop tools to integrate existing theories or formulate new theories; conceptual frameworks to organize or fuse data to infer general principles of brain function; multiscale/multiphysics models to generate new testable hypotheses to design/drive future experiments; new analytical methods to either support or refute a stated hypothesis about brain function. It is expected that the tools developed under this FOA will be made widely available to the neuroscience research community for their use and modification. Investigative studies should be limited to model parameter estimation and/or validity testing of the tools being developed.

Grant Title: Centers on the Demography and Economics of Aging, Including Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (D and E Centers) (P30 Clinical Trial Optional) aims to support interdisciplinary research centers that focus on the social science aspects of aging, particularly related to health disparities, economic impacts, and caregiving for dementia, while fostering collaboration among diverse scholars and institutions.

The National Cancer Institute (NCI) intends to issue the U54 Specialized Programs of Research Excellence in Cancer Health Disparities and Minority Health (CHD-MH SPORE) notice of funding opportunity (NOFO). The program will support a network of multidisciplinary, multi-institutional U54 CHD-MH SPOREs, which are multi-project awards uniquely focused on health disparities and/or minority health translational research for improved prevention, early detection, diagnosis, and treatment of cancer in populations who are underserved. U54 CHD-MH SPOREs can investigate more than one cancer type in underserved populations, including groups of highly related cancers (e.g., gastrointestinal or head and neck). The research supported through this program must be translational and must stem from research on human biology, addressing the interplay of various determinants of health with the biology of the disease. U54 CHD-MH SPORE projects must have the goal of reaching a translational human endpoint within the project period of the grant, which may include a clinical trial. This Notice of Intent to Publish is being provided to allow sufficient time for applicants to develop strong applications. The NOFO is expected to be published in late winter 2024 with only one expected application due date in late September 2024.

This grant provides funding for research projects that explore the complex processes of cancer metastasis, encouraging collaboration among institutions to improve understanding and treatment of metastatic diseases.

This funding opportunity supports research projects aimed at improving health outcomes for Native American populations by developing and testing culturally appropriate health interventions.

This funding opportunity supports research on policies affecting tobacco, alcohol, and cannabis use in underserved communities, aiming to promote health equity and reduce disparities in substance exposure and use.

This funding opportunity provides financial support for research aimed at improving the spread and implementation of effective health interventions, particularly in underserved communities, with a focus on promoting health equity and addressing health disparities.

This funding opportunity supports the establishment of a central coordinating center to enhance collaboration, data sharing, and community engagement in cancer immunoprevention research, with a focus on inclusivity and support for early-career scientists.

This funding opportunity supports researchers in developing new screening methods and treatments for serious genetic conditions in newborns that could greatly benefit from early detection and intervention.

The "Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research" grant aims to encourage existing NCI P30 centers to enhance their current research by integrating new technologies from the NCI Innovative Molecular Analysis Technologies program, with the goal of advancing cancer research and promoting scientific discovery.

The purpose of the Cancer Immunoprevention Network (CIP-Net) is to support a deeper understanding of basic mechanisms of immunoprevention, discover novel immunoprevention strategies, and foster a community of cancer immunoprevention researchers. ?The UG3/UH3 research projects will enable de novo discovery of immune pathways, immunoprevention mechanisms, or investigation of new vaccine or immunomodulatory targets or agents. Applicants responding to this FOA must apply for both the UG3 and UH3 phases together in a single application. Achievement of the UG3 milestones will be necessary for transition to the UH3 phase. UH3 phase may be awarded after administrative review of the UG3 milestones. Provided these milestones are achieved, UH3 phase may continue.

This grant provides funding to organizations that evaluate and improve healthcare delivery by using patient-centered research to reduce disparities in care, particularly for underserved populations.

This funding opportunity provides financial support to healthcare systems and organizations to improve Hepatitis C prevention, testing, and treatment for individuals with substance use disorders and severe mental illness, particularly in communities affected by homelessness.

State Promotion of Strategies to Advance Oral Health is a three-year competitive announcement that continues the Centers for Disease Control and Prevention's investment in supporting oral health programs. This Funding Opportunity Announcement aims to enable recipients to focus on priority populations and the following strategies: 1) access to optimally fluoridated water and receipt of Evidence-based Preventive Dental Services, 2) adherence to infection prevention and control recommendations, 3) access to data to build evidence for public health practice, and 4) access to care and untreated decay, and 5) foundational information supporting integrated medical and dental services for persons with diabetes. The proposed program follows previous Notice of Funding Opportunities (NOFOs) and incorporates programmatic strategies implemented in NOFO DP18-1810 [FY2018 FY2023].

This funding opportunity supports innovative research projects aimed at developing new treatments and improving recovery processes for individuals with alcohol use disorder, particularly in underserved populations.